Arrowhead Pharmaceuticals, Inc. (ARWR) has a market capitalization of $9.34B and trades at $66.69. The 52-week range is 9.57-76.76.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -5466.4, Earnings Per Share (EPS) of $-0.01, annual revenue of $829.45M.
The stock has a beta of 1.27, operates in the Healthcare sector.
